Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Brandon D Liebelt1, Takashi Shingu2, Xin Zhou2
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, TX 77030, USA.
Stem Cells International
|February 17, 2016
Summary
Glioma stem cells (GSCs) drive glioblastoma resistance and recurrence. Targeting these unique cells and their role in tumor vascularization offers new therapeutic strategies for brain tumors.
Area of Science:
- Neuro-oncology
- Cancer Stem Cell Biology
- Tumor Microenvironment
Background:
- Glioblastoma is an aggressive brain tumor with poor outcomes despite standard treatments.
- A subpopulation of glioma stem cells (GSCs) is implicated in treatment resistance and tumor recurrence.
- GSCs exhibit self-renewal, differentiation, and de novo tumor formation capabilities.
Purpose of the Study:
- To review current knowledge on glioma stem cell biology and function.
- To explore the role of GSCs in glioblastoma vascular formation.
- To discuss potential therapeutic strategies targeting GSCs.
Main Methods:
- Literature review of glioblastoma and glioma stem cell research.
- Analysis of GSC characteristics, including surface markers and signaling pathways.
- Examination of GSC involvement in tumor angiogenesis.
Main Results:
- GSCs possess unique markers and signaling pathways crucial for tumorigenesis.
- GSCs contribute significantly to the formation of new blood vessels in gliomas.
- GSCs are key drivers of glioblastoma's resistance to conventional therapies.
Conclusions:
- Understanding GSC biology is critical for developing effective glioblastoma treatments.
- Targeting GSCs and their role in angiogenesis presents a promising therapeutic avenue.
- Further research into GSC-specific therapies could improve patient outcomes for glioblastoma.
